Industry leading team

At Polpharma Biologics, our passion for excellence begins at the top.

With decades of combined experience in the development, manufacture and commercialization of biopharmaceuticals, our international management team brings both knowledge and passion to every project.

Key people of Polpharma Biologics group companies

Our key executives manages the operational running of the business, the team bring experience from many global biotechnology companies.

"It is here that new molecules, active substances and drugs for the largest companies in the world are created"

Jerzy Starak

Chairman, Polpharma Biologics Group

“We care about delivering on our commitments”

Hannes Teissl

Vice Chairman, Polpharma Biologics Group

“We are passionate about getting safe and effective medicines to patients”

Dr Joerg Windisch

President & CEO, Polpharma Biologics Group

"We care about delivering on our commitments"

Jan Krzewiński

President, Polpharma Biologics Gdańsk

“We work with dedication and find innovative solutions”

Frederic Papp

President, Polpharma Biologics Warsaw

“We are experts in managing projects, transparent communicators and always deliver on our commitments”

Alexandra Moulson

VP Programs, Portfolio & Strategy, Polpharma Biologics Gdańsk

“Our patients expect and deserve high quality and innovative medicines”

Mathieu Ballie

VP Quality, Polpharma Biologics Group

“We are self-motivated to reach the end result, wait and see is not in our vocabulary”

Frank Ternes

Global Head of CDMO, Polpharma Biologics Warsaw

“We value everyone equally and always treat each other with respect ”

Lidia Ołowska

VP People & Organization, Polpharma Biologics Gdańsk

“We care about being respectful and transparent”

Agnieszka Kosowska

Director of Legal & Public Affairs, Polpharma Biologics Gdańsk

“We work with dedication and find innovative solutions”

Dr Adriana Kiędzierska-Mencfeld

VP TechOps, Polpharma Biologics Gdańsk

Advisory board

Our advisory board brings immense expertise with international experience in the development of novel biologics and biosimilars.

Hans Peter Hasler

Member of the Advisory Board

Wolf Berthold

Member of the Advisory Board

Let’s collaborate and create quality biologics together.

Get in touch for more information.

We use cookies

Polpharma Biologics uses cookies and other similar technologies (hereinafter: cookies) on its webpages and mobile applications (hereinafter, jointly, Website). The user can manage cookies independently by changing the web browser settings. If you do not consent for your personal data to be collected via cookies, you should change your web browser settings or stop using the Website.

Using the Website without changing the web browser settings indicates your acceptance of the use of cookies by Polpharma. Acceptance of the web browser settings indicates your consent to profiling on the basis of the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect lawfulness of any processing activities carried out under consent before its withdrawal.

For more details see the Cookie Policy.